NF Research Initiative

Team

NF Research Initiative Team


NFRI Team and GeM Coordinating Center

 
static1.squarespace.jpg

Director of NFRI

David Miller, MD, PhD

Dr. Miller is board-certified in Medical Genetics and cares for patients with NF1 in the Multidisciplinary Neurofibromatosis Program at Boston Children’s Hospital where he is the Program Director. He is also currently leading an effort to update the clinical practice guidelines for children with Neurofibromatosis Type 1. Dr. Miller is also an expert in clinical genetic testing and serves as a Medical Director at Claritas Genomics (a subsidiary of Boston Children’s Hospital). Dr. Miller received his M.D. and Ph.D. degrees from Washington University School of Medicine in St. Louis, completed a residency in Pediatrics at Yale-New Haven Hospital, and residency/fellowship in medical genetics and clinical molecular genetics at Harvard Medical School. He is an Associate Professor of Pediatrics at Harvard Medical School, and an active contributor to the Human Genetics course at the Medical School. Dr. Miller’s experience as a clinician who orders genetic tests and provides results directly to patients, combined with expertise in developing and performing clinical laboratory diagnostic assays, provides him with a unique and valuable perspective at the interface of genomic technology and clinical care.

 

Education

WASHINGTON UNIVERSITY IN ST. LOUIS SCHOOL OF MEDICINE
MD, PhD, Biological Sciences, 1999

UNIVERSITY OF KENTUCKY
BS Biology; BA Chemistry, 1991

 

 
 
static1.squarespace.jpg

resident

Diane Shao, MD, PhD

Dr. Shao is a Pediatric Neurology resident at Boston Children's Hospital. She is interested in the basic biology of malignant tumors in Neurofibromatosis. She received her M.D. and Ph.D. degrees from Harvard Medical School. During her Ph.D., she used genomic screening technology to identify new cancer susceptibilities, focusing in particular on the Ras pathway, the pathway directly affected in NF1. Her goals are to leverage results from cutting edge genetic techniques to advance understanding of tumor development, and ultimately translate those results into actionable clinical decisions.

 

Education

HARVARD MEDICAL SCHOOL MD, PhD, 2015

RICE UNIVERSITY
B.S. Biochemistry; B.A. Statistics, 2007

 

 
 
Piculell_Katherine-007.jpg

clinical research coordinator

Katherine Piculell, MPH

Katherine joined the NFRI as Clinical Research Study Coordinator in 2017. Her professional interests include epidemiology, program development and evaluation, clinical research, and sexual and reproductive health.

 

Education

BOSTON UNIVERSITY, SCHOOL OF PUBLIC HEALTH
MPH, Epidemiology and Maternal & Child Health, 2016

UNIVERSITY OF CALIFORNIA, SANTA CRUZ
B.A., Anthropology, 2008

 

 
 
Topister-Bonyos-photo300x300-e1492101518939.jpg

pROJECT COORDINATOR

Topister Bonyo, MPH

Topi is the project coordinator for  NFRI. She joined the team in January of 2019. Her interests include medicine,  global health and sports (volleyball and weightlifting).

Education

KENT STATE UNIVERSITY, SCHOOL OF PUBLIC HEALTH

MPH, Health Policy and Management, 2018.

KENT STATE UNIVERSITY

B.S. Pre-medicine Biology and Chemistry, 2012.